Stock AZTR AZITRAPAR
Add to a list
To use this feature you must be a member
Log inSign up

News AZITRAPAR

Equities

AZTR

US05479L1044

Real-time Estimate Cboe BZX
Other stock markets
 21:04:36 28/06/2024 BST 		5-day change 1st Jan Change
0.097 USD -26.52% Intraday chart for AZITRAPAR -28.34% -89.39%
06-16 Certain Options of Azitra, Inc. are subject to a Lock-Up Agreement Ending on 16-JUN-2024. CI
06-16 Certain Warrants of Azitra, Inc. are subject to a Lock-Up Agreement Ending on 16-JUN-2024. CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Azitra, Inc. Announces Reverse Stock Split
BU
Certain Options of Azitra, Inc. are subject to a Lock-Up Agreement Ending on 16-JUN-2024.
CI
Certain Warrants of Azitra, Inc. are subject to a Lock-Up Agreement Ending on 16-JUN-2024.
CI
Certain Common Stock of Azitra, Inc. are subject to a Lock-Up Agreement Ending on 16-JUN-2024.
CI
Azitra, Inc. Announces Presentation at the 2024 BIO International Convention
AQ
Azitra, Inc. Announces Presentation at the 2024 BIO International Convention
BU
Azitra Announces Positive Preclinical Data from ATR-04 Presented at the Society of Investigative Dermatology Annual Meeting
AQ
Azitra, Inc. Announces Positive Preclinical Data from ATR-04 Presented at the Society of Investigative Dermatology Annual Meeting
BU
Azitra, Inc. Announces Positive Preclinical Data of ATR-12 and Clinical Design in Netherton Syndrome Presented at the ASGCT Annual Meeting
AQ
Azitra, Inc. Announces Positive Preclinical Data of ATR-12 and Clinical Design in Netherton Syndrome Presented at the ASGCT Annual Meeting
BU
Azitra, Inc. Announces Positive Preclinical Data of ATR-12 and Clinical Design in Netherton Syndrome Presented at the ASGCT Annual Meeting
CI
Azitra, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Azitra, Inc. Announces Q1 2024 Financial Results and Provides Business Updates
BU
Azitra, Inc. Announces New Preclinical Data to be Presented at the American Society of Gene and Cell Therapy Meeting
BU
Azitra, Inc. Announces New Preclinical Data to be Presented at the American Society of Gene and Cell Therapy Meeting
CI
Azitra, Inc. to Present New Data at Three Upcoming Scientific Conferences in May 2024
BU
Azitra, Inc. Announces Full Year 2023 Financial Results and Provides Business Updates
BU
Azitra, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Azitra Closes $5 Million Public Offering
MT
Azitra, Inc. Announces Closing of Public Offering
BU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AZTR Stock
  4. News AZITRAPAR